XPRESSPA GROUP INC (XSPA)
US98420U7037 - Common Stock
XPRESSPA GROUP INC
NASDAQ:XSPA (10/24/2022, 7:00:02 PM)
After market: 0.6501 0 (-0.75%)0.655
-0.04 (-5.65%)
Company Profile
XpresSpa Group, Inc. provides global travel health and wellness services. The company is headquartered in New York City, New York and currently employs 363 full-time employees. The company went IPO on 2010-06-18. The Company’s segments include XpresSpa, XpresTest and Treat. The XpresSpa segment provides travelers premium spa services, including massage, nail and skin care, as well as spa and travel products. The XpresTest segment provides diagnostic COVID-19 tests at XpresCheck Wellness Centers in airports, to airport employees and to the traveling public. The Treat segment provides access to integrated care and is designed to deliver on-demand access to integrated healthcare through technology and personalized services, positioned for a traveler to access health care, records and real-time information. The firm operates in two geographical regions: United States and all other countries, which include Amsterdam, and Dubai.
Company Info
XPRESSPA GROUP INC
254 West 31St Street, 11Th Floor
New York City NEW YORK 10001
P: 12123097549.0
CEO: Douglas Satzman
Employees: 363
Website: http://xpresspagroup.com/
XSPA News
a year ago - InvestorPlace7 Penny Stocks That Actually Have Buy RatingsThis article makes a bullish case for seven penny stocks with buy ratings, and gives you reasons why they may still be risky.
XWELL’s third Treat location showcases continued expansion in health and wellness...
New suite of curated products for women are clean, sustainable and primarily sourced from women-owned companies...
XpresCheck, through its Partnership with Ginkgo Bioworks, Awarded New CDC Biosurveillance Contract Valued Up To $61 Million Leading Health and Wellness...
Public-private partnership to enable the development of innovative, sustainable infrastructure designed to set the global standard for travel biosecurity...
2 years ago - Ginkgo BioworksGinkgo Bioworks and XpresCheck Receive Award to Expand CDC's Traveler-Based SARS-CoV-2 Genomic Surveillance Program In U.S. Airports/PRNewswire/ -- Ginkgo Bioworks (NYSE: DNA) and XpresSpa Group, Inc. (Nasdaq: XSPA) announced they will continue to support the Centers for Disease Control and...
XSPA Twits
Here you can normally see the latest stock twits on XSPA, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits:
